Literature DB >> 23239141

Cholesteatoma growth and proliferation: relevance with serpin B3.

Kuen-Yao Ho1, Han Hsiang Huang, Kuo-Feng Hung, Jiing-Chuan Chen, Chee-Yin Chai, Wan-Tzu Chen, Shih-Meng Tsai, Chen-Yu Chien, Hsun-Mo Wang, Yu-Jen Wu.   

Abstract

OBJECTIVES/HYPOTHESIS: The mechanisms of cholesteatoma proliferation and growth remain unclear. The objective of this study is to discover the potential mechanisms of the proliferation and growth of cholesteatoma by direct experimental assessments on cholesteatoma tissues from patients. STUDY
DESIGN: Retrospective study by the comparisons between cholesteatoma tissues and retroauricular skin tissues from the patients.
METHODS: Two-dimensional gel electrophoresis, LC-MS/MS analysis and immunohistochemistry were performed to investigate specific protein expression in cholesteatoma tissues compared with retroauricular skin tissues collected from the patients. Western blotting analysis was conducted to verify the regulation of specific proteins found by 2-DE, and to determine the changes of associated potential modulators in cholesteatoma proliferation and growth.
RESULTS: Twelve serpin B3 isoforms were found by 2-DE and identified by LC-MS/MS analysis, which is coherent with the results exhibited by immunohistochemistry and western blot. Up-regulation of STAT3 and down-regulations of cathepsin K and cathepsin L were represented using western blot.
CONCLUSIONS: The data in this study suggested serpin B3, STAT3, cathepsin K, and cathepsin L are associated with the proliferation and growth of cholesteatoma, and these proteins may be influential factors in cholesteatoma growth.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23239141     DOI: 10.1002/lary.23547

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3).

Authors:  Cristian Turato; Patrizia Pontisso
Journal:  Atlas Genet Cytogenet Oncol Haematol       Date:  2015

2.  Activation of the IL-6/JAK/STAT3 signaling pathway in human middle ear cholesteatoma epithelium.

Authors:  Wei Liu; Shumin Xie; Xing Chen; Xingwang Rao; Hongmiao Ren; Bing Hu; Tuanfang Yin; Yuyan Xiang; Jihao Ren
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

3.  Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.

Authors:  Anders Britze; Rune Isak Dupont Birkler; Niels Gregersen; Therese Ovesen; Johan Palmfeldt
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

4.  Identification of altered protein abundances in cholesteatoma matrix via mass spectrometry-based proteomic analysis.

Authors:  Derrick R Randall; Phillip S Park; Justin K Chau
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-11-25

5.  TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation.

Authors:  Huaili Jiang; Yu Si; Zhuohao Li; Xi Huang; Suijun Chen; Yiqing Zheng; Guo Xu; Ximing Chen; Yubin Chen; Yi Liu; Hao Xiong; Qiuhong Huang; Maojin Liang; Zhigang Zhang
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.